Payment overview · 2025
General Payments
$143.57
1 reported records · 1 companies
Healthcare provider profile · identity verified
Jennifer C Maneja, MD
Allopathic & Osteopathic Physicians|Internal Medicine|Geriatric Medicine · EFFINGHAM, IL · NPI 1194775064
Verified facts
What the public records show
CMS Open Payments records show Jennifer C Maneja, MD received $143.57 in general payments during 2025 across 1 reported records.
Abbott Laboratories accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Abbott Laboratories | Unresolved — no canonical attribution shown | $143.57 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $143.57 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| ETERNA Normalized: eterna |
Device | Abbott Laboratories | $143.57 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 872 | 176 |
| Levothyroxine Sodium | Levothyroxine Sodium | 619 | 111 |
| Lisinopril | Lisinopril | 483 | 99 |
| Gabapentin | Gabapentin | 427 | 69 |
| Omeprazole | Omeprazole | 427 | 93 |
| Losartan Potassium | Losartan Potassium | 418 | 85 |
| Furosemide | Furosemide | 334 | 51 |
| Amlodipine Besylate | Amlodipine Besylate | 302 | 65 |
| Montelukast Sodium | Montelukast Sodium | 299 | 74 |
| Potassium Chloride | Potassium Chloride | 265 | 50 |
| Duloxetine Hcl | Duloxetine Hcl | 256 | 39 |
| Metoprolol Succinate | Metoprolol Succinate | 238 | 50 |
| Hydrochlorothiazide | Hydrochlorothiazide | 211 | 45 |
| Metformin Hcl | Metformin Hcl | 211 | 54 |
| Famotidine | Famotidine | 207 | 34 |
| Sertraline Hcl | Sertraline Hcl | 207 | 40 |
| Simvastatin | Simvastatin | 205 | 45 |
| Warfarin Sodium | Warfarin Sodium | 197 | 27 |
| Pantoprazole Sodium | Pantoprazole Sodium | 189 | 42 |
| Clopidogrel | Clopidogrel Bisulfate | 183 | 34 |
| Escitalopram Oxalate | Escitalopram Oxalate | 177 | 31 |
| Tamsulosin Hcl | Tamsulosin Hcl | 168 | 32 |
| Carvedilol | Carvedilol | 163 | 32 |
| Metoprolol Tartrate | Metoprolol Tartrate | 161 | 32 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 158 | 47 |
| Ezetimibe | Ezetimibe | 157 | 37 |
| Pravastatin Sodium | Pravastatin Sodium | 147 | 30 |
| Meloxicam | Meloxicam | 146 | 38 |
| Citalopram Hbr | Citalopram Hydrobromide | 134 | 22 |
| Buspirone Hcl | Buspirone Hcl | 131 | 21 |
| Ozempic | Semaglutide | 131 | 17 |
| Allopurinol | Allopurinol | 128 | 24 |
| Eliquis | Apixaban | 128 | 23 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 109 | 20 |
| Fluticasone Propionate | Fluticasone Propionate | 109 | 38 |
| Atenolol | Atenolol | 101 | 17 |
| Ropinirole Hcl | Ropinirole Hcl | 99 | 15 |
| Fenofibrate | Fenofibrate Nanocrystallized | 97 | 16 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 95 | 39 |
| Trazodone Hcl | Trazodone Hcl | 92 | 24 |
| Glipizide | Glipizide | 91 | 15 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 89 | 15 |
| Donepezil Hcl | Donepezil Hcl | 85 | 15 |
| Metformin Hcl Er | Metformin Hcl | 85 | 20 |
| Farxiga | Dapagliflozin Propanediol | 84 | 12 |
| Alendronate Sodium | Alendronate Sodium | 80 | 17 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 77 | 23 |
| Zolpidem Tartrate | Zolpidem Tartrate | 77 | 15 |
| Enalapril Maleate | Enalapril Maleate | 75 | 16 |
| Fluoxetine Hcl | Fluoxetine Hcl | 75 | 13 |
| Pregabalin | Pregabalin | 72 | 14 |
| Finasteride | Finasteride | 66 | suppressed |
| Xarelto | Rivaroxaban | 66 | suppressed |
| Alprazolam | Alprazolam | 58 | 11 |
| Azithromycin | Azithromycin | 58 | 39 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 57 | 11 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 56 | 13 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 55 | suppressed |
| Glimepiride | Glimepiride | 54 | 13 |
| Celecoxib | Celecoxib | 52 | 14 |
| Diclofenac Sodium | Diclofenac Sodium | 51 | 14 |
| Glipizide Er | Glipizide | 51 | 13 |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 48 | suppressed |
| Levetiracetam | Levetiracetam | 47 | suppressed |
| Clonazepam | Clonazepam | 46 | suppressed |
| Spironolactone | Spironolactone | 44 | suppressed |
| Jardiance | Empagliflozin | 43 | suppressed |
| Lovastatin | Lovastatin | 43 | suppressed |
| Valsartan | Valsartan | 43 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 42 | 12 |
| Mirtazapine | Mirtazapine | 41 | 13 |
| Oxybutynin Chloride | Oxybutynin Chloride | 41 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 40 | 12 |
| Tramadol Hcl | Tramadol Hcl | 39 | 14 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 39 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 38 | suppressed |
| Aripiprazole | Aripiprazole | 37 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 37 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 36 | suppressed |
| Np Thyroid | Thyroid,pork | 35 | suppressed |
| Diazepam | Diazepam | 33 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 32 | 26 |
| Risperidone | Risperidone | 32 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 32 | 11 |
| Amitriptyline Hcl | Amitriptyline Hcl | 31 | suppressed |
| Myrbetriq | Mirabegron | 31 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 30 | suppressed |
| Lorazepam | Lorazepam | 30 | suppressed |
| Prednisone | Prednisone | 30 | 14 |
| Breo Ellipta | Fluticasone/Vilanterol | 29 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 29 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 28 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 28 | suppressed |
| Nifedipine Er | Nifedipine | 27 | suppressed |
| Memantine Hcl | Memantine Hcl | 26 | suppressed |
| Bupropion Xl | Bupropion Hcl | 25 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 25 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 25 | suppressed |
| Methylprednisolone | Methylprednisolone | 24 | 20 |
| Naproxen | Naproxen | 24 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 22 | suppressed |
| Lamotrigine | Lamotrigine | 22 | suppressed |
| Linzess | Linaclotide | 22 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 22 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 21 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 21 | 17 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 20 | suppressed |
| Sucralfate | Sucralfate | 20 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 19 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 18 | suppressed |
| Nystatin | Nystatin | 18 | suppressed |
| Synthroid | Levothyroxine Sodium | 18 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 17 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 17 | 11 |
| Repatha Syringe | Evolocumab | 17 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 17 | suppressed |
| Verapamil Sr | Verapamil Hcl | 17 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 16 | 16 |
| Clonidine Hcl | Clonidine Hcl | 16 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 16 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 16 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 16 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 16 | 13 |
| Acyclovir | Acyclovir | 15 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 15 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 15 | suppressed |
| Januvia | Sitagliptin Phosphate | 15 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 15 | suppressed |
| Ramipril | Ramipril | 15 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 14 | 12 |
| Primidone | Primidone | 14 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 13 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 13 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 13 | suppressed |
| Trulicity | Dulaglutide | 13 | suppressed |
| Carbamazepine Er | Carbamazepine | 12 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 12 | suppressed |
| Methimazole | Methimazole | 12 | suppressed |
| Rybelsus | Semaglutide | 12 | suppressed |
| Topiramate | Topiramate | 12 | suppressed |
| Torsemide | Torsemide | 12 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Cephalexin | Cephalexin | 11 | 11 |
| Chlorthalidone | Chlorthalidone | 11 | suppressed |
| Latanoprost | Latanoprost | 11 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 11 | suppressed |
| Ondansetron Odt | Ondansetron | 11 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 11 | suppressed |
| Telmisartan | Telmisartan | 11 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 11 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Zafirlukast | Zafirlukast | 11 | suppressed |
| Zenpep | Lipase/Protease/Amylase | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $143.57 · 1 records | Abbott Laboratories | ETERNA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error